These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
514 related articles for article (PubMed ID: 20825488)
1. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France. Perrin-Terrin A; Pathak A; Lapeyre-Mestre M Fundam Clin Pharmacol; 2011 Aug; 25(4):503-10. PubMed ID: 20825488 [TBL] [Abstract][Full Text] [Related]
2. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Mayet S; Gossop M; Lintzeris N; Markides V; Strang J Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918 [TBL] [Abstract][Full Text] [Related]
3. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. Pearson EC; Woosley RL Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):747-53. PubMed ID: 15918160 [TBL] [Abstract][Full Text] [Related]
4. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations. Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of long QTc interval in methadone maintenance patients. Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907 [TBL] [Abstract][Full Text] [Related]
7. Torsades de pointes with methadone. Prescrire Int; 2005 Apr; 14(76):61-2. PubMed ID: 15875343 [TBL] [Abstract][Full Text] [Related]
8. Heterogeneous impact of methadone on the QTc interval: what are the practical implications? Krantz MJ J Addict Dis; 2008; 27(4):5-9. PubMed ID: 19042586 [TBL] [Abstract][Full Text] [Related]
9. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. Ehret GB; Voide C; Gex-Fabry M; Chabert J; Shah D; Broers B; Piguet V; Musset T; Gaspoz JM; Perrier A; Dayer P; Desmeules JA Arch Intern Med; 2006 Jun; 166(12):1280-7. PubMed ID: 16801510 [TBL] [Abstract][Full Text] [Related]
10. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy. Roy AK; McCarthy C; Kiernan G; McGorrian C; Keenan E; Mahon NG; Sweeney B Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435 [TBL] [Abstract][Full Text] [Related]
11. [Routine ECG in methadone-assisted rehabilitation is wrong prioritization]. Krook AL; Waal H; Hansteen V Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2940-1. PubMed ID: 15550974 [TBL] [Abstract][Full Text] [Related]
12. [Review of cases of prolonged QTC and wave burst arrhythmia in patients treated with methadone]. Laqueille X; Richa S; Kerbage H; Scart-Gres C; Berleur MP Encephale; 2012 Feb; 38(1):58-63. PubMed ID: 22381725 [TBL] [Abstract][Full Text] [Related]
13. [Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database]. Rochoy M; Auffret M; Béné J; Gautier S; Rev Epidemiol Sante Publique; 2017 Feb; 65(1):1-8. PubMed ID: 27988172 [TBL] [Abstract][Full Text] [Related]
14. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study. Peles E; Bodner G; Kreek MJ; Rados V; Adelson M Addiction; 2007 Feb; 102(2):289-300. PubMed ID: 17222284 [TBL] [Abstract][Full Text] [Related]
15. Methadone-induced long QT syndrome vs methadone-induced torsades de pointes. Justo D Arch Intern Med; 2006 Nov; 166(20):2288; author reply 2289-90. PubMed ID: 17101953 [No Abstract] [Full Text] [Related]
17. QTc prolongation and torsades de pointes associated with methadone therapy. Routhier DD; Katz KD; Brooks DE J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991 [TBL] [Abstract][Full Text] [Related]
18. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes? Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294 [TBL] [Abstract][Full Text] [Related]
19. Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database. Aström-Lilja C; Odeberg JM; Ekman E; Hägg S Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):587-92. PubMed ID: 18449951 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms and risks of electrocardiographic QT interval prolongation when using antipsychotic drugs. Vieweg WV J Clin Psychiatry; 2002; 63 Suppl 9():18-24. PubMed ID: 12088172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]